How2Exit

MARCH 31, 2024

Get the Insider Tips You Need to Secure Your Deal - Watch Here rn rn About the Guest(s): rn Patrick O'Connell is an experienced mergers and acquisitions (M&A) advisor with a profound depth of knowledge in buying and selling small businesses valued between one to $20 million. b' E200: Buying or Selling a Small Business?

Business 130

Business Mergers and Acquisitions Securities M&A 130

Cooley M&A

JANUARY 22, 2021

General Trends in Life Sciences M&A. In contrast, aggregate M&A deal value for the life sciences sector was down nearly 50% when compared to 2019, with the first half of 2020 particularly dismal in the wake of market uncertainty caused by the pandemic.

M&A 40

M&A Mergers and Acquisitions Collaboration Mergers 40

Cooley M&A

FEBRUARY 8, 2018

What’s on tap for 2018 M&A? As an example, for California specific requirements, see our prior blog post Non-Competes for California Employees in M&A Deals: Don’t Fudge It. A recap of 2017 trends and the Cooley outlook on this year’s dealmaking: Buying Innovation: Retention and Non-Competes.

M&A 52

M&A Mergers and Acquisitions Mergers Negotiation 52

Solganick & Co.

SEPTEMBER 2, 2024

September 2, 2024 – The software mergers and acquisitions (M&A) marketplace has been bustling with activity in the first half of 2024, reflecting the sector’s robust growth and strategic consolidations. The Top Software M&A Transactions Announced so far in 2024 include: January 2024: Synopsys announced a $31.9

Mergers and Acquisitions 52

Mergers and Acquisitions Acquisitions Mergers M&A 52

Wizenius

JUNE 28, 2023

Valuation is a complex art that requires a deep understanding of financial modeling and various influencing factors. Below are few factors that shape growth rate assumptions and present real-world examples from different geographies to shed light on the art of valuation.

DCF 52

DCF Financial Modeling Financial Models Discounted Cash Flow 52

Peak Frameworks

SEPTEMBER 18, 2023

Consider a pharmaceutical giant like Pfizer , which imports raw materials for its drugs. The Importance of FOB for Financial Professionals Valuation Considerations FOB can directly impact the valuation of goods. Freight on Board or FOB is a shipping term that defines when the buyer/seller becomes responsible for the shipment.

Private Equity 52

Private Equity Negotiation Transportation Valuation 52

Devensoft

MAY 25, 2023

We, at Devensoft, help companies with their end-to-end M&A and have worked with several clients in the corporate sector to navigate this complex process. Understanding merger vs acquisition Mergers and acquisitions (M&A) are two of the most common forms of corporate restructuring.

Corporation 52

Corporation Mergers Mergers and Acquisitions Acquisitions 52

M&A Leadership Council

JUNE 12, 2023

Insights & Advice: An Interview with Two Experts By Mark Herndon, Chairman Emeritus, M&A Leadership Council Cybersecurity and IT due diligence has become one of the most challenging, and also one of the most critical areas of due diligence in any environment. Tell us more about that. What is the business trying to accomplish?

IT 52

IT M&A Securities Insurance 52

Peak Frameworks

SEPTEMBER 19, 2023

company to hit a $1 trillion valuation , it directly benefited shareholders. The distinction between them is crucial for understanding a company's obligations, its strategy, and the interplay of interests within its ecosystem. What is a Shareholder? A shareholder is an individual or entity that owns shares or stock in a corporation.

Corporation 52

Corporation Private Equity Mergers and Acquisitions Corporate Finance 52

InvestmentBank.com

SEPTEMBER 18, 2019

Major Players in the M&A Scene Amazon’s acquisition of PillPack is the largest acquisition of a DTC nutraceutical company on record with a $753 million price tag in 2018. Simplicity, transparency, and trust fuel the growth of the nutritional supplement industry. until 2025 [2]. They account for $3.67 billion in sales annually in the U.S

Food 52

Food Valuation Acquisitions M&A 52

M&A Leadership Council

SEPTEMBER 9, 2021

By Mark Herndon, Chairman, M&A Leadership Council . The risks of brand damage, customer churn, and substantial costs have brought this topic to the forefront in many recent M&A Leadership Council workshops. Tell us more about that. Mark Dickelman (MD): Start by understanding the value proposition of the deal itself.

IT 52

IT M&A Securities Insurance 52

Cooley M&A

JANUARY 20, 2022

General trends in life sciences M&A. While 2020’s M&A landscape was characterized by whiplash volatility from choppy deal activity in the first half of the year to a surge in volume in the second half, that momentum accelerated in 2021, with no signs of slowing down heading into 2022. driven assets.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

Cooley M&A

JANUARY 30, 2024

8] M&A-themed campaigns (sell the company/division or agitation against an announced transaction) made up 49% of all activism campaigns globally, well above the trailing four-year average of 42%. [9] 9] We expect the prevalence of M&A-themed campaigns to remain elevated in 2024 as M&A levels bounce back from 2023 levels.

Private Equity 52

Private Equity M&A Capital Investors 52

OfficeHours

JANUARY 26, 2024

That hadn’t previously been the case since 2009 and highlights how falling valuations and tighter credit markets have forced firms to keep assets for longer than typical five-year investment cycles. If you want to get a deal done in the first half, you had better be starting conversations with buyers in February.”

Private Equity 130

Private Equity Equities Mergers and Acquisitions Investors 130

Cooley M&A

JULY 10, 2017

Similarly, sellers (particularly financial investors) in private M&A transactions are increasingly seeking the right to be able to monetize their rights to contingent consideration by requesting royalty-like earn-out streams and requesting a right to sell the potential future payments to a single third-party purchaser. Private placement.

Securities 52

Securities IT Investors M&A 52

Cooley M&A

OCTOBER 29, 2018

M&A practitioners have long advised boards of directors that the Delaware courts have never found that the events or circumstances in a particular transaction met the contractual standard of having a material adverse effect (or MAE) as defined in a merger or acquisition agreement. We can no longer give this advice. 2018-0300-JTL (Del.

Mergers and Acquisitions 52

Mergers and Acquisitions Mergers Business Pharmaceutical 52

Software Equity Group

AUGUST 20, 2024

The software landscape is dynamic, and strategic buyers are continuously seeking new and innovative ways to gain a competitive edge. One strategy gaining momentum is the acquisition of high-growth SaaS companies. This trend goes beyond simply acquiring market share; it creates a win-win scenario for both parties.

Investment 52

Investment Management Acquisitions Business 52

Mergers and Inquisitions

NOVEMBER 1, 2023

Mispriced Companies and Assets – Some mature healthcare firms trade at low valuation multiples , often because the market misunderstands their contracts, revenue, or track record. When you hear the words “healthcare private equity,” two thoughts probably come to mind: Wait a minute, isn’t healthcare a risky/growth-oriented sector?

Private Equity 59

Private Equity Healthcare Equities Middle Market 59

Cooley M&A

FEBRUARY 15, 2017

So far this year, deal parties are approaching M&A with cautious optimism. Over the next few days, we will run a series of Cooley M&A blog posts with some brief observations that offer some M&A highlights over the past year and our thoughts for the year to come. Cautious Optimism in the New Year.

M&A 40

M&A IPO Pharmaceutical Valuation 40

InvestmentBank.com

MAY 18, 2021

The healthcare industry is formed of numerous subsectors including pharmaceutical services, diagnostics, medical technologies, and managed healthcare. Payor services and pharmaceutical services have generated the most return throughout 2016 and in 1Q 2017. The pharmaceutical industry is valued highly given the performance of buyouts.

Healthcare 40

Healthcare M&A Valuation Hospitality 40